Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16
Published January 31, 2024 · Recall initiated: December 29, 2023
Summary
FDA records drug Class II recall D-0260-2024, published January 31, 2024 and initiated December 29, 2023. Recalling firm: Strides Pharma Inc.; Status: Terminated; Reported quantity: 396 50-count bottles; Lot: Lot #: 7253092B, Exp Date 09/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if METHOXSALEN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHOXSALEN
- Manufacturer
- Strides Pharma Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0364380752165
- Lot
- Lot #: 7253092B, Exp Date 09/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only,January 31, 2024
- FDABleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by:January 31, 2024
- FDAVasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis,January 31, 2024
- FDAFosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only afterJanuary 31, 2024
- FDABenzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by:January 31, 2024
- FDACinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc.,January 31, 2024
Questions about this recall
Was Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16 recalled?
Yes. FDA published recall D-0260-2024 on January 31, 2024. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHOXSALEN. UPC: 0364380752165.